DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Hilton Lac-Leamy

2026年10月26日 (月) 午前 7:30 - 2026年10月27日 (火) 午後 4:00

3 Boulevard du Casino, Gatineau, QC J8Y 6X4, Canada

Canada Annual Meeting

The Canada Annual Meeting offers three tracks, Regulatory, Clinical, Safety and Pharmacovigilance!

Session 4, Track B: Supporting the Interface Between Community-led Engagement and Researchers: Partners in Clinical Trial Development

Session Chair(s)

Erin  Cherban

Erin Cherban

Chief Clinical Research Officer, Centre For Advancing Health Outcomes/Ctn+, Canada

Katalin  Bertenyi, MSc

Katalin Bertenyi, MSc

Manager, Centre for Blood, Blood Products and Biotherapeutics, Health Canada, Canada

Clinical trials development has advanced to full inclusion of patient-partners in proposing and participating in the early development phase of clinical research studies and trials. This session will focus on the educational tools and resources that community members have developed for training new community members and researchers to assist in early development of trials. This session will also feature a presentation from Health Canada that provides an overview of Health Canada’s clinical trials transparency initiative that includes a searchable Canadian clinical trials portal.

Learning Objective :
  • Gain understanding principles for collaborating with community on clinical trial development
  • Understand balance between engaging community members in a tokenistic fashion versus meaningful collaboration
  • Learn about training resources to assist your company with meaningful community engagement
  • Learn about Health Canada’s new tool for community members to search for Canadian clinical trials

Speaker(s)

Muluba  Habanyama

Speaker

Muluba Habanyama

Director of Communications and Programs, Ontario AIDS Network, Canada

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。